Return to Trial Database

HCRN-GU17-294

Phase 2 Trial of Tremelimumab in Patients With Metastatic Urothelial Cancer Previously Treated With PD-1/PD-L1 Blockade

Status

Study Completed

Cancer Type(s)

Bladder Urothelial Carcinoma

Study Contact

Publications

Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade

Trial Locations

All sites in which the trial HCRN-GU17-294 being conducted in.

No data was found